Law360, New York (October 07, 2009) -- Impax Laboratories Inc. has reached an agreement with drugmakers Astellas Pharma Inc. and Boehringer Ingelheim Pharmaceuticals Inc. to settle a patent dispute related to a generic version of Flomax, a drug used to treat the symptoms of an enlarged prostate.
Impax announced the settlement Wednesday, saying that the agreement will give Impax the opportunity to launch a generic version of Flomax on March 2, 2010, before the expiration of pediatric...
